[Clinical experience with the use of rivaroxaban in the treatment of cancer patients with venous thrombosis].

Unlabelled: The urgency of the problem. The incidence of various thromboembolic complications in patients with oncopathology reaches 5-12%. When treating VTE in patients with oncology it is necessary to choose between two generally recognized alternatives.